The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Author： de la Torre Beatriz G.   Albericio Fernando  

Publisher： MDPI

E-ISSN： 1420-3049|23|3|533-533

ISSN： 1420-3049

Source： Molecules, Vol.23, Iss.3, 2018-02, pp. : 533-533

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Pharmaceutical Industry in 2016. An Analysis of FDA Drug Approvals from a Perspective of the Molecule Type

By de la Torre Beatriz G.   Albericio Fernando  

Molecules, Vol. 22, Iss. 3, 2017-02 ,pp. : 368-368

MDPI

Access to resources Recommend Favorite

Acknowledgement to Reviewers of Molecules in 2017

By  

Molecules, Vol. 23, Iss. 1, 2018-01 ,pp. : 138-138

MDPI

Access to resources Recommend Favorite

Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry

By Wijesekara Isuru   Kim Se-Kwon  

Marine Drugs, Vol. 8, Iss. 4, 2010-03 ,pp. : 1080-1093

MDPI

Access to resources Recommend Favorite

QSAR-Assisted Virtual Screening of Lead-Like Molecules from Marine and Microbial Natural Sources for Antitumor and Antibiotic Drug Discovery

By Pereira Florbela   Latino Diogo A. R. S.   Gaudêncio Susana P.  

Molecules, Vol. 20, Iss. 3, 2015-03 ,pp. : 4848-4873

MDPI

Access to resources Recommend Favorite

Molecular Mechanisms of Pharmaceutical Drug Binding into Calsequestrin

By Subra Arun K.   Nissen Mark S.   Lewis Kevin M.   Muralidharan Ashwin K.   Sanchez Emiliano J.   Milting Hendrik   Kang ChulHee  

International Journal of Molecular Sciences, Vol. 13, Iss. 11, 2012-11 ,pp. : 14326-14343

MDPI

Access to resources Recommend Favorite